Trial Profile
Clinical Trials Insight: 700052492
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 12 Jan 2010
Price :
$35
*
At a glance
- Drugs ApoB SNALP (Primary)
- Indications Hypercholesterolaemia
- Focus Adverse reactions
- Sponsors Arbutus Biopharma
- 12 Jan 2010 New trial record
- 11 Jan 2010 Temkira intends to initiate this trial in the second half of 2010.